Reid Raleigh, PA
Medical · Annapolis, MDNPI 1780772707
Payments from drug & device makers
Across 51 payments — averaging $21.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$312
- E.r. Squibb & Sons, L.L.C.$114
- Novartis$101
- Johnson & Johnson$99
- Galderma Laboratories, L.p.$69
- Lilly USA, LLC$64
- plus $351 from 12 others
What the payments were for
- Food & beverage$1,01091%
- Education$999%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 15 | $312 |
| E.r. Squibb & Sons, L.L.C. | 7 | $114 |
| Novartis | 5 | $101 |
| Johnson & Johnson | 1 | $99 |
| Galderma Laboratories, L.p. | 4 | $69 |
| Lilly USA, LLC | 3 | $64 |
| Incyte Corporation | 2 | $53 |
| Almirall LLC | 2 | $45 |
| Dermavant Sciences, Inc. | 2 | $44 |
| Boehringer Ingelheim | 1 | $32 |
| Arcutis Biotherapeutics, Inc. | 2 | $31 |
| LEO Pharma Inc. | 1 | $27 |
| Amgen | 1 | $23 |
| Sun Pharmaceutical Industries Inc. | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Nabriva Therapeutics, PLC | 1 | $18 |
| Pfizer | 1 | $17 |
How this compares
$1,109 in reported general payments places this provider in the 65th percentile of 543 medical providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 95 | $6,704 |
| Desonide | 14 | $2,535 |
| Ketoconazole | 86 | $1,660 |
| Metronidazole | 28 | $1,645 |
| Fluorouracil | 17 | $1,015 |
| Halobetasol Propionate | 20 | $979 |
| Tretinoin | 11 | $756 |
| Fluocinonide | 14 | $693 |
| Triamcinolone Acetonide | 50 | $614 |
| Hydrocortisone | 31 | $613 |
| Doxycycline Hyclate | 21 | $566 |
| Mupirocin | 45 | $417 |
| Clindamycin Phosphate | 15 | $412 |
| ValacyclovirValacyclovir Hcl | 15 | $214 |
| Ammonium Lactate | 11 | $182 |
Paid to pharmacies, not to this prescriber.
Other medical in Annapolis
- Karen ScottAnnapolis$49K
- Mary HolthausAnnapolis$11K
- Molly WarnockAnnapolis$8K
- Victoria TrottStevensville$94K
- Sarah SagorskyBaltimore$68K
- Emily GrisnikLeonardtown$62K
- Jennifer HamiltonBel Air$52K
- Kristina TrunnellFrederick$51K
- Nicholas WunderAberdeen$40K
- Sarah JamiesonFrederick$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.